As of 2025-08-05, the Intrinsic Value of Caplin Point Laboratories Ltd (CAPLIPOINT.NS) is 1,119.64 INR. This CAPLIPOINT.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2,008.60 INR, the upside of Caplin Point Laboratories Ltd is -44.30%.
The range of the Intrinsic Value is 956.35 - 1,372.71 INR
Based on its market price of 2,008.60 INR and our intrinsic valuation, Caplin Point Laboratories Ltd (CAPLIPOINT.NS) is overvalued by 44.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 956.35 - 1,372.71 | 1,119.64 | -44.3% |
| DCF (Growth 10y) | 1,339.23 - 1,930.10 | 1,572.87 | -21.7% |
| DCF (EBITDA 5y) | 2,297.58 - 2,755.40 | 2,456.77 | 22.3% |
| DCF (EBITDA 10y) | 2,540.65 - 3,295.76 | 2,832.07 | 41.0% |
| Fair Value | 1,421.68 - 1,421.68 | 1,421.68 | -29.22% |
| P/E | 1,876.84 - 2,099.89 | 1,943.80 | -3.2% |
| EV/EBITDA | 1,679.05 - 1,839.44 | 1,717.89 | -14.5% |
| EPV | 435.32 - 506.90 | 471.11 | -76.5% |
| DDM - Stable | 379.19 - 759.89 | 569.54 | -71.6% |
| DDM - Multi | 725.77 - 1,143.22 | 889.01 | -55.7% |
| Market Cap (mil) | 152,673.69 |
| Beta | 1.46 |
| Outstanding shares (mil) | 76.01 |
| Enterprise Value (mil) | 146,809.78 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.69% |
| Cost of Debt | 10.52% |
| WACC | 14.69% |